Showing results (1271-1280 of 4,880) with videos related to
Sort By:
Pageof 488
Urologic Oncology|July 5, 2006
Insulin-like growth factors and their binding proteins in prostate cancer: cause or consequence?David S Meinbach, Bal L LokeshwarUrologic Oncology|July 5, 2006
Molecular markers in bladder cancer: a critical appraisalBadrinath R KonetyUrologic Oncology|May 8, 2007
Does a delay in initiating definitive therapy affect biochemical recurrence rates in men with clinically localized prostate cancer?Joseph J Phillips, M Craig Hall, W Robert Lee, et al.Urologic Oncology|May 8, 2007
The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancerMark L Gonzalgo, Ram H Datar, Mark P Schoenberg, et al.Urologic Oncology|May 8, 2007
Inflammation in the etiology of prostate cancer: an epidemiologic perspectiveSiobhan Sutcliffe, Elizabeth A PlatzUrologic Oncology|May 8, 2021
Prospective validation of the Kaiser Permanente prostate cancer risk calculator in a contemporary, racially diverse, referral populationJoseph C Presti, Stacey Alexeeff, Brandon Horton, et al.Urologic Oncology|June 25, 2020
The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohortFlorian Janisch, Tobias Hillemacher, Constantin Fuehner, et al.Urologic Oncology|June 25, 2020
Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancerErica Stevens, Mathew Truong, Jennifer A Bullen, et al.Urologic Oncology|June 20, 2020
Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practiceNoelia Sanmamed, Rachel M Glicksman, Jaime Herrera-Caceres, et al.Urologic Oncology|June 9, 2020
Urologic oncology surgery during COVID-19: a rapid review of current triage guidance documentsBrian M Shinder, Hiren V Patel, Joshua Sterling, et al.Pageof 488